ICD-10-CM category
T42: Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs
Codes under T42 (Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs). A ✓ marks a billable (fully specified) code; category codes without a ✓ are not billable on their own.
| Code | Description | Billable |
|---|---|---|
| T42.0 | Poisoning by, adverse effect of and underdosing of hydantoin derivatives | — |
| T42.0X | Poisoning by, adverse effect of and underdosing of hydantoin derivatives | — |
| T42.0X1 | Poisoning by hydantoin derivatives, accidental (unintentional) | — |
| T42.0X1A | Poisoning by hydantoin derivatives, accidental (unintentional), initial encounter | ✓ |
| T42.0X1D | Poisoning by hydantoin derivatives, accidental (unintentional), subsequent encounter | ✓ |
| T42.0X1S | Poisoning by hydantoin derivatives, accidental (unintentional), sequela | ✓ |
| T42.0X2 | Poisoning by hydantoin derivatives, intentional self-harm | — |
| T42.0X2A | Poisoning by hydantoin derivatives, intentional self-harm, initial encounter | ✓ |
| T42.0X2D | Poisoning by hydantoin derivatives, intentional self-harm, subsequent encounter | ✓ |
| T42.0X2S | Poisoning by hydantoin derivatives, intentional self-harm, sequela | ✓ |
| T42.0X3 | Poisoning by hydantoin derivatives, assault | — |
| T42.0X3A | Poisoning by hydantoin derivatives, assault, initial encounter | ✓ |
| T42.0X3D | Poisoning by hydantoin derivatives, assault, subsequent encounter | ✓ |
| T42.0X3S | Poisoning by hydantoin derivatives, assault, sequela | ✓ |
| T42.0X4 | Poisoning by hydantoin derivatives, undetermined | — |
| T42.0X4A | Poisoning by hydantoin derivatives, undetermined, initial encounter | ✓ |
| T42.0X4D | Poisoning by hydantoin derivatives, undetermined, subsequent encounter | ✓ |
| T42.0X4S | Poisoning by hydantoin derivatives, undetermined, sequela | ✓ |
| T42.0X5 | Adverse effect of hydantoin derivatives | — |
| T42.0X5A | Adverse effect of hydantoin derivatives, initial encounter | ✓ |
| T42.0X5D | Adverse effect of hydantoin derivatives, subsequent encounter | ✓ |
| T42.0X5S | Adverse effect of hydantoin derivatives, sequela | ✓ |
| T42.0X6 | Underdosing of hydantoin derivatives | — |
| T42.0X6A | Underdosing of hydantoin derivatives, initial encounter | ✓ |
| T42.0X6D | Underdosing of hydantoin derivatives, subsequent encounter | ✓ |
| T42.0X6S | Underdosing of hydantoin derivatives, sequela | ✓ |
| T42.1 | Poisoning by, adverse effect of and underdosing of iminostilbenes | — |
| T42.1X | Poisoning by, adverse effect of and underdosing of iminostilbenes | — |
| T42.1X1 | Poisoning by iminostilbenes, accidental (unintentional) | — |
| T42.1X1A | Poisoning by iminostilbenes, accidental (unintentional), initial encounter | ✓ |
| T42.1X1D | Poisoning by iminostilbenes, accidental (unintentional), subsequent encounter | ✓ |
| T42.1X1S | Poisoning by iminostilbenes, accidental (unintentional), sequela | ✓ |
| T42.1X2 | Poisoning by iminostilbenes, intentional self-harm | — |
| T42.1X2A | Poisoning by iminostilbenes, intentional self-harm, initial encounter | ✓ |
| T42.1X2D | Poisoning by iminostilbenes, intentional self-harm, subsequent encounter | ✓ |
| T42.1X2S | Poisoning by iminostilbenes, intentional self-harm, sequela | ✓ |
| T42.1X3 | Poisoning by iminostilbenes, assault | — |
| T42.1X3A | Poisoning by iminostilbenes, assault, initial encounter | ✓ |
| T42.1X3D | Poisoning by iminostilbenes, assault, subsequent encounter | ✓ |
| T42.1X3S | Poisoning by iminostilbenes, assault, sequela | ✓ |
| T42.1X4 | Poisoning by iminostilbenes, undetermined | — |
| T42.1X4A | Poisoning by iminostilbenes, undetermined, initial encounter | ✓ |
| T42.1X4D | Poisoning by iminostilbenes, undetermined, subsequent encounter | ✓ |
| T42.1X4S | Poisoning by iminostilbenes, undetermined, sequela | ✓ |
| T42.1X5 | Adverse effect of iminostilbenes | — |
| T42.1X5A | Adverse effect of iminostilbenes, initial encounter | ✓ |
| T42.1X5D | Adverse effect of iminostilbenes, subsequent encounter | ✓ |
| T42.1X5S | Adverse effect of iminostilbenes, sequela | ✓ |
| T42.1X6 | Underdosing of iminostilbenes | — |
| T42.1X6A | Underdosing of iminostilbenes, initial encounter | ✓ |
| T42.1X6D | Underdosing of iminostilbenes, subsequent encounter | ✓ |
| T42.1X6S | Underdosing of iminostilbenes, sequela | ✓ |
| T42.2 | Poisoning by, adverse effect of and underdosing of succinimides and oxazolidinediones | — |
| T42.2X | Poisoning by, adverse effect of and underdosing of succinimides and oxazolidinediones | — |
| T42.2X1 | Poisoning by succinimides and oxazolidinediones, accidental (unintentional) | — |
| T42.2X1A | Poisoning by succinimides and oxazolidinediones, accidental (unintentional), initial encounter | ✓ |
| T42.2X1D | Poisoning by succinimides and oxazolidinediones, accidental (unintentional), subsequent encounter | ✓ |
| T42.2X1S | Poisoning by succinimides and oxazolidinediones, accidental (unintentional), sequela | ✓ |
| T42.2X2 | Poisoning by succinimides and oxazolidinediones, intentional self-harm | — |
| T42.2X2A | Poisoning by succinimides and oxazolidinediones, intentional self-harm, initial encounter | ✓ |
| T42.2X2D | Poisoning by succinimides and oxazolidinediones, intentional self-harm, subsequent encounter | ✓ |
| T42.2X2S | Poisoning by succinimides and oxazolidinediones, intentional self-harm, sequela | ✓ |
| T42.2X3 | Poisoning by succinimides and oxazolidinediones, assault | — |
| T42.2X3A | Poisoning by succinimides and oxazolidinediones, assault, initial encounter | ✓ |
| T42.2X3D | Poisoning by succinimides and oxazolidinediones, assault, subsequent encounter | ✓ |
| T42.2X3S | Poisoning by succinimides and oxazolidinediones, assault, sequela | ✓ |
| T42.2X4 | Poisoning by succinimides and oxazolidinediones, undetermined | — |
| T42.2X4A | Poisoning by succinimides and oxazolidinediones, undetermined, initial encounter | ✓ |
| T42.2X4D | Poisoning by succinimides and oxazolidinediones, undetermined, subsequent encounter | ✓ |
| T42.2X4S | Poisoning by succinimides and oxazolidinediones, undetermined, sequela | ✓ |
| T42.2X5 | Adverse effect of succinimides and oxazolidinediones | — |
| T42.2X5A | Adverse effect of succinimides and oxazolidinediones, initial encounter | ✓ |
| T42.2X5D | Adverse effect of succinimides and oxazolidinediones, subsequent encounter | ✓ |
| T42.2X5S | Adverse effect of succinimides and oxazolidinediones, sequela | ✓ |
| T42.2X6 | Underdosing of succinimides and oxazolidinediones | — |
| T42.2X6A | Underdosing of succinimides and oxazolidinediones, initial encounter | ✓ |
| T42.2X6D | Underdosing of succinimides and oxazolidinediones, subsequent encounter | ✓ |
| T42.2X6S | Underdosing of succinimides and oxazolidinediones, sequela | ✓ |
| T42.3 | Poisoning by, adverse effect of and underdosing of barbiturates | — |
| T42.3X | Poisoning by, adverse effect of and underdosing of barbiturates | — |
| T42.3X1 | Poisoning by barbiturates, accidental (unintentional) | — |
| T42.3X1A | Poisoning by barbiturates, accidental (unintentional), initial encounter | ✓ |
| T42.3X1D | Poisoning by barbiturates, accidental (unintentional), subsequent encounter | ✓ |
| T42.3X1S | Poisoning by barbiturates, accidental (unintentional), sequela | ✓ |
| T42.3X2 | Poisoning by barbiturates, intentional self-harm | — |
| T42.3X2A | Poisoning by barbiturates, intentional self-harm, initial encounter | ✓ |
| T42.3X2D | Poisoning by barbiturates, intentional self-harm, subsequent encounter | ✓ |
| T42.3X2S | Poisoning by barbiturates, intentional self-harm, sequela | ✓ |
| T42.3X3 | Poisoning by barbiturates, assault | — |
| T42.3X3A | Poisoning by barbiturates, assault, initial encounter | ✓ |
| T42.3X3D | Poisoning by barbiturates, assault, subsequent encounter | ✓ |
| T42.3X3S | Poisoning by barbiturates, assault, sequela | ✓ |
| T42.3X4 | Poisoning by barbiturates, undetermined | — |
| T42.3X4A | Poisoning by barbiturates, undetermined, initial encounter | ✓ |
| T42.3X4D | Poisoning by barbiturates, undetermined, subsequent encounter | ✓ |
| T42.3X4S | Poisoning by barbiturates, undetermined, sequela | ✓ |
| T42.3X5 | Adverse effect of barbiturates | — |
| T42.3X5A | Adverse effect of barbiturates, initial encounter | ✓ |
| T42.3X5D | Adverse effect of barbiturates, subsequent encounter | ✓ |
| T42.3X5S | Adverse effect of barbiturates, sequela | ✓ |
| T42.3X6 | Underdosing of barbiturates | — |
| T42.3X6A | Underdosing of barbiturates, initial encounter | ✓ |
| T42.3X6D | Underdosing of barbiturates, subsequent encounter | ✓ |
| T42.3X6S | Underdosing of barbiturates, sequela | ✓ |
| T42.4 | Poisoning by, adverse effect of and underdosing of benzodiazepines | — |
| T42.4X | Poisoning by, adverse effect of and underdosing of benzodiazepines | — |
| T42.4X1 | Poisoning by benzodiazepines, accidental (unintentional) | — |
| T42.4X1A | Poisoning by benzodiazepines, accidental (unintentional), initial encounter | ✓ |
| T42.4X1D | Poisoning by benzodiazepines, accidental (unintentional), subsequent encounter | ✓ |
| T42.4X1S | Poisoning by benzodiazepines, accidental (unintentional), sequela | ✓ |
| T42.4X2 | Poisoning by benzodiazepines, intentional self-harm | — |
| T42.4X2A | Poisoning by benzodiazepines, intentional self-harm, initial encounter | ✓ |
| T42.4X2D | Poisoning by benzodiazepines, intentional self-harm, subsequent encounter | ✓ |
| T42.4X2S | Poisoning by benzodiazepines, intentional self-harm, sequela | ✓ |
| T42.4X3 | Poisoning by benzodiazepines, assault | — |
| T42.4X3A | Poisoning by benzodiazepines, assault, initial encounter | ✓ |
| T42.4X3D | Poisoning by benzodiazepines, assault, subsequent encounter | ✓ |
| T42.4X3S | Poisoning by benzodiazepines, assault, sequela | ✓ |
| T42.4X4 | Poisoning by benzodiazepines, undetermined | — |
| T42.4X4A | Poisoning by benzodiazepines, undetermined, initial encounter | ✓ |
| T42.4X4D | Poisoning by benzodiazepines, undetermined, subsequent encounter | ✓ |
| T42.4X4S | Poisoning by benzodiazepines, undetermined, sequela | ✓ |
| T42.4X5 | Adverse effect of benzodiazepines | — |
| T42.4X5A | Adverse effect of benzodiazepines, initial encounter | ✓ |
| T42.4X5D | Adverse effect of benzodiazepines, subsequent encounter | ✓ |
| T42.4X5S | Adverse effect of benzodiazepines, sequela | ✓ |
| T42.4X6 | Underdosing of benzodiazepines | — |
| T42.4X6A | Underdosing of benzodiazepines, initial encounter | ✓ |
| T42.4X6D | Underdosing of benzodiazepines, subsequent encounter | ✓ |
| T42.4X6S | Underdosing of benzodiazepines, sequela | ✓ |
| T42.5 | Poisoning by, adverse effect of and underdosing of mixed antiepileptics | — |
| T42.5X | Poisoning by, adverse effect of and underdosing of antiepileptics | — |
| T42.5X1 | Poisoning by mixed antiepileptics, accidental (unintentional) | — |
| T42.5X1A | Poisoning by mixed antiepileptics, accidental (unintentional), initial encounter | ✓ |
| T42.5X1D | Poisoning by mixed antiepileptics, accidental (unintentional), subsequent encounter | ✓ |
| T42.5X1S | Poisoning by mixed antiepileptics, accidental (unintentional), sequela | ✓ |
| T42.5X2 | Poisoning by mixed antiepileptics, intentional self-harm | — |
| T42.5X2A | Poisoning by mixed antiepileptics, intentional self-harm, initial encounter | ✓ |
| T42.5X2D | Poisoning by mixed antiepileptics, intentional self-harm, subsequent encounter | ✓ |
| T42.5X2S | Poisoning by mixed antiepileptics, intentional self-harm, sequela | ✓ |
| T42.5X3 | Poisoning by mixed antiepileptics, assault | — |
| T42.5X3A | Poisoning by mixed antiepileptics, assault, initial encounter | ✓ |
| T42.5X3D | Poisoning by mixed antiepileptics, assault, subsequent encounter | ✓ |
| T42.5X3S | Poisoning by mixed antiepileptics, assault, sequela | ✓ |
| T42.5X4 | Poisoning by mixed antiepileptics, undetermined | — |
| T42.5X4A | Poisoning by mixed antiepileptics, undetermined, initial encounter | ✓ |
| T42.5X4D | Poisoning by mixed antiepileptics, undetermined, subsequent encounter | ✓ |
| T42.5X4S | Poisoning by mixed antiepileptics, undetermined, sequela | ✓ |
| T42.5X5 | Adverse effect of mixed antiepileptics | — |
| T42.5X5A | Adverse effect of mixed antiepileptics, initial encounter | ✓ |
| T42.5X5D | Adverse effect of mixed antiepileptics, subsequent encounter | ✓ |
| T42.5X5S | Adverse effect of mixed antiepileptics, sequela | ✓ |
| T42.5X6 | Underdosing of mixed antiepileptics | — |
| T42.5X6A | Underdosing of mixed antiepileptics, initial encounter | ✓ |
| T42.5X6D | Underdosing of mixed antiepileptics, subsequent encounter | ✓ |
| T42.5X6S | Underdosing of mixed antiepileptics, sequela | ✓ |
| T42.6 | Poisoning by, adverse effect of and underdosing of other antiepileptic and sedative-hypnotic drugs | — |
| T42.6X | Poisoning by, adverse effect of and underdosing of other antiepileptic and sedative-hypnotic drugs | — |
| T42.6X1 | Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional) | — |
| T42.6X1A | Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter | ✓ |
| T42.6X1D | Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), subsequent encounter | ✓ |
| T42.6X1S | Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), sequela | ✓ |
| T42.6X2 | Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm | — |
| T42.6X2A | Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter | ✓ |
| T42.6X2D | Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, subsequent encounter | ✓ |
| T42.6X2S | Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, sequela | ✓ |
| T42.6X3 | Poisoning by other antiepileptic and sedative-hypnotic drugs, assault | — |
| T42.6X3A | Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, initial encounter | ✓ |
| T42.6X3D | Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, subsequent encounter | ✓ |
| T42.6X3S | Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, sequela | ✓ |
| T42.6X4 | Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined | — |
| T42.6X4A | Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter | ✓ |
| T42.6X4D | Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined, subsequent encounter | ✓ |
| T42.6X4S | Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined, sequela | ✓ |
| T42.6X5 | Adverse effect of other antiepileptic and sedative-hypnotic drugs | — |
| T42.6X5A | Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | ✓ |
| T42.6X5D | Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter | ✓ |
| T42.6X5S | Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela | ✓ |
| T42.6X6 | Underdosing of other antiepileptic and sedative-hypnotic drugs | — |
| T42.6X6A | Underdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter | ✓ |
| T42.6X6D | Underdosing of other antiepileptic and sedative-hypnotic drugs, subsequent encounter | ✓ |
| T42.6X6S | Underdosing of other antiepileptic and sedative-hypnotic drugs, sequela | ✓ |
| T42.7 | Poisoning by, adverse effect of and underdosing of unspecified antiepileptic and sedative-hypnotic drugs | — |
| T42.8 | Poisoning by, adverse effect of and underdosing of antiparkinsonism drugs and other central muscle-tone depressants | — |
| T42.8X | Poisoning by, adverse effect of and underdosing of antiparkinsonism drugs and other central muscle-tone depressants | — |
| T42.8X1 | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional) | — |
| T42.8X1A | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional), initial encounter | ✓ |
| T42.8X1D | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional), subsequent encounter | ✓ |
| T42.8X1S | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional), sequela | ✓ |
| T42.8X2 | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm | — |
| T42.8X2A | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, initial encounter | ✓ |
| T42.8X2D | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, subsequent encounter | ✓ |
| T42.8X2S | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, sequela | ✓ |
| T42.8X3 | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault | — |
| T42.8X3A | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault, initial encounter | ✓ |
| T42.8X3D | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault, subsequent encounter | ✓ |
| T42.8X3S | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault, sequela | ✓ |
| T42.8X4 | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined | — |
| T42.8X4A | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined, initial encounter | ✓ |
| T42.8X4D | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined, subsequent encounter | ✓ |
| T42.8X4S | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined, sequela | ✓ |
| T42.8X5 | Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants | — |
| T42.8X5A | Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | ✓ |
| T42.8X5D | Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter | ✓ |
| T42.8X5S | Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela | ✓ |
| T42.8X6 | Underdosing of antiparkinsonism drugs and other central muscle-tone depressants | — |
| T42.8X6A | Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter | ✓ |
| T42.8X6D | Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter | ✓ |
| T42.8X6S | Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, sequela | ✓ |
| T42.71 | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional) | — |
| T42.71XA | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter | ✓ |
| T42.71XD | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional), subsequent encounter | ✓ |
| T42.71XS | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional), sequela | ✓ |
| T42.72 | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm | — |
| T42.72XA | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter | ✓ |
| T42.72XD | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, subsequent encounter | ✓ |
| T42.72XS | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, sequela | ✓ |
| T42.73 | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault | — |
| T42.73XA | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault, initial encounter | ✓ |
| T42.73XD | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault, subsequent encounter | ✓ |
| T42.73XS | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault, sequela | ✓ |
| T42.74 | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined | — |
| T42.74XA | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter | ✓ |
| T42.74XD | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined, subsequent encounter | ✓ |
| T42.74XS | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined, sequela | ✓ |
| T42.75 | Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs | — |
| T42.75XA | Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | ✓ |
| T42.75XD | Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter | ✓ |
| T42.75XS | Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela | ✓ |
| T42.76 | Underdosing of unspecified antiepileptic and sedative-hypnotic drugs | — |
| T42.76XA | Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | ✓ |
| T42.76XD | Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter | ✓ |
| T42.76XS | Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, sequela | ✓ |
More free billing tools: all ICD-10 categories · ICD-10 search · denial codes · Medicare fees
Informational only, not coding or medical advice. Verify against the official ICD-10-CM (FY2026) and your payer's guidelines.
Code the diagnosis right
Join providers across the country delivering modern virtual care with CareNiva. Free to start, ready in minutes.
100% Satisfaction Guaranteed — try it risk-free